Mainolfi Nello Insider Trades & Stock Holdings

Chief Executive Officer · Kymera Therapeutics, Inc. · Latest filing Oct 1, 2026

Mainolfi Nello, Chief Executive Officer at Kymera Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($3.41M), net -$3.41M. Latest filing: disposed of 30K shares of $KYMR on Oct 1, 2026 at $113.80.

Trades on file

1

Open-market bought

$0

Open-market sold

$3.41M

Net open-market

-$3.41M

Latest filing

Oct 1, 2026

All insider trades by Mainolfi Nello

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$KYMR	Sell (Open-market sale) 10b5-1	30K	$113.80	$3.41M			-0.7%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Mainolfi Nello traded

• $KYMR

Frequently asked questions

Has Mainolfi Nello been buying or selling stock?

Mainolfi Nello has 0 open-market purchases and 1 open-market sale on file, net -$3.41M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Mainolfi Nello's latest insider trade?

disposed of 30K shares of $KYMR on Oct 1, 2026 at $113.80.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.